Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Brazil
Bupropion

Anvisa 2025

Bupropion, Naltrexone

cloridrato de bupropiona + cloridrato de naltrexona

BrazilAuthorisedAuthorised 8 Sept 2025

Ask Osler about it

On this page

In other countries
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

MysimbaEuropean Union · Orexigen Therapeutics Ireland LimitedSame form
MysimbaCroatiaSame form
MYSIMBA 8 mg/90 mgRomania · 8mg/90mg · compr. elib. prel. · Orexigen Therapeutics Ireland LimitedSame form
ContraveSaudi Arabia · Patheon INCSame form
ContraveCanada · 90 MG + 8 MG · Tablet (Extended-Release) · Bausch Health, Canada INC.Same substance
Mysimba 8 MG/90 MG Comprimidos de Liberacion ProlongadaSpain · 8 mg + 90 mg · comprimido de liberación prolongada · Orexigen Therapeutics Ireland LimitedSame substance
MysimbaItaly · Compressa a rilascio prolungato · Orexigen Therapeutics Ireland LimitedSame substance

More with the same substance on this register

BupnalBupropion + NaltrexoneBrazil
ContraveBupropion + NaltrexoneBrazil

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

🇳🇱Mysimba 8 mg/90 mg tabletten met verlengde afgifteNetherlands · Tablet met verlengde afgifte · Orexigen Therapeutics Ireland LimitedSame substance

🇷🇸Mysimba®Serbia · 90mg+8mg · tableta sa produženim oslobađanjem · Pharmaswiss D.O.O., BeogradSame substance

🇸🇬Contrave Prolonged Release Tablet 8MG/90MGSingapore · 90mg + 8.00mg · tablet, film coated, extended release · Inova Pharmaceuticals (Singapore) Pte. LimitedSame substance

🇺🇸ContraveUnited States · 90MG; 8MG · tablet, extended release · NalpropionSame substance

🇺🇸Naltrexone Hydrochloride; Bupropion HydrochlorideUnited States · 8MG/90MG · tablet, extended release · Actavis Labs FL INCSame substance

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Bupropion, Naltrexone
Register: Brazil (Anvisa)
Status: Authorised
Status in the register: Ativo
Authorised: 8 Sept 2025
Registration: 100431553
Marketing authorisation holder: Eurofarma Laboratorios S.A.
ATC code: A08A
Group: Alimentary tract and metabolism
Procedure: Registered

Anvisa

ReduxaltBupropion + Naltrexone🇧🇷Brazil

AnvisaSlivBupropion + Naltrexone🇧🇷Brazil